At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
Ciprofloxacindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomised, Open, Parallel Group Clinical Trial to Compare the Efficacy and Safety of a Single Dose of Ciprofloxacin Oral Suspension 20 mg/kg With a 3-day Course of Erythromycin Oral Suspension Administered in a Dose of 12.5 mg/kg Every 6 Hours (12 Doses) in the Treatment of Children,With Clinically Severe Cholera Due to V. Cholerae O1 or O139.
International Centre for Diarrhoeal Disease Research, Bangladesh·interventional·Posted Sep 2, 2005·Updated Feb 11, 2022
In Brief
A Phase 3 clinical trial evaluating Ciprofloxacin for Cholera. Completed, across 1 site.
Detailed Summary
The study will be conducted to compare the efficacy and safety of a single dose of ciprofloxacin oral suspension 20 mg/kg with a 3-day course of erythromycin oral suspension administered in a dose of 12.5 mg/kg every 6 hours (12 doses) in the treatment of children, aged 2-15 years with clinically severe cholera due to V. cholerae O1 or O139. We hypothesize that single dose ciprofloxacin would result in similar outcome in the clinicalcurewith that of erythromycin given in multiple doses.
Study Details
Timeline
Phase 3CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2001
Study CompletionJul 2002
First PostedSep 2005
TodayJul 2026
First PostedSep 2, 2005
Enrollment StartMay 1, 2001
Study CompletionJul 1, 2002
TodayJul 2, 2026
Posted 20.8 years ago
Interventions
Ciprofloxacindrug